AMAG Pharmaceuticals
Lexington
About AMAG Pharmaceuticals
AMAG Pharmaceuticals is a biopharmaceutical company, which utilizes the technology for the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and imaging agents to aid in the diagnosis of cancer and cardiovascular disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 251 – 500
- Estimated revenue: $100K – $500K
- Total funding: $475.0M
- Funding stage: M&A
- Last round: Post-IPO Debt (May 2017)
- Ticker: nasdaq:AMAG
- Website: amagpharma.com
- Phone: +1 617 902 2368
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/amag-pharmaceuticals-203791 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.